RecruitingNot ApplicableNCT05547984

Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA)

A Randomized Controlled Trial Comparing Modular Dual Mobility Inserts With Ceramic Multilayer Coating Versus Standard Polyethylene Inserts for Primary Total Hip Arthroplasty (THA) in a Cementless Acetabular Cup

Sponsor

Aesculap AG

Enrollment

100 participants

Start Date

Nov 21, 2022

Study Type

INTERVENTIONAL

Conditions

Coxarthrosis; Primary

Summary

A randomized controlled trial comparing modular dual mobility inserts with ceramic multilayer coating versus standard polyethylene inserts for primary THA in a cementless acetabular cup

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Dual Mobility Cup and a medical device called Standard Acetabular component for people with coxarthrosis; primary. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDual Mobility Cup

Total hip arthroplasty (THA) is a successful and established therapy for coxarthrosis, rheumatic arthritis, hip fractures and femoral head necrosis. The acetabular implant for this arm is the Dual Mobility cup

DEVICEStandard Acetabular component

Locations(1)

Masaryk Hospital

Ústí nad Labem, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05547984